Market Trends of Laser Capture Microdissection Industry
Diagnostics is Expected to Register a Highest CAGR Over the Forecast Period
Currently, microdissection of tissue sections and cytological preparations have been used increasingly for the isolation of homogeneous, morphologically identified cell populations, thus, overcoming the obstacle of tissue complexity. In conjunction with sensitive analytical techniques, such as the polymerase chain reaction, microdissection allows precise in vivo examination of cell populations, such as carcinoma in situ, or the malignant cells of Hodgkin's disease, which are otherwise inaccessible for conventional molecular studies.
Laser Capture Microdissection (LCM) may allow the establishment of "genetic fingerprints" of specific pathological lesions, especially malignant neoplasms. In addition to the identification of new diagnostic and prognostic markers, this approach could help in establishing individualized treatment, tailored to the molecular profile of a tumor. Thus, the increased application of LCM in diagnostics is augmenting the growth of the market.
North America to Dominate the Market
Geographically, North America is dominating the global laser capture micro-dissection market, primairly due to the availability of skilled personnel. Also, due to robust healthcare infrastructure in the United States, which is coupled with extensive funding for medical research projects. This will continue to fuel the adoption of laser capture micro-dissection in North America. It has been observed that Asia-Pacific will be the fastest-growing market for laser capture microdissection, mainly due to the rising investment in healthcare R&D in Asian countries.
